SPEAKER SPOTLIGHT – Prof. Elie Azoulay – Keynote Lecture

Patients treated with new immunotherapies for cancer in the ICU   Over the last two decades, survival rates in patients with solid tumors and hematological malignancies have greatly improved. Molecular targeted therapy and cell therapy have improved disease-control, but their related life-threatening adverse events often require critical care management. Although generally well tolerated compared to […]

Read More…